InvestorsHub Logo
Followers 239
Posts 12059
Boards Moderated 0
Alias Born 08/14/2003

Re: Riley4 post# 679150

Sunday, 03/17/2024 1:14:20 AM

Sunday, March 17, 2024 1:14:20 AM

Post# of 689399
I actually can't make that comparison, I believe that DCVax-L has the potential of being one of the highest selling products, especially if it gains the tumor agnostic label. I frankly have no idea how much has been earned with my meds, but some like Gleevec, were blockbusters, and may still be. I happen to have great insurance, my out of pocket for all authorized drugs is close to nothing regardless of the list price. I have no idea how much the insurers pay, but I doubt if it's near the list price for most products.

I hate to say it, but it probably will be true that insurers will make deals to lower what they pay for the DCVax's regardless of what the list price is. Regardless, our DCVax's will be blockbusters many times over.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News